PHARMACOECONOMIC ANALYSIS OF MARAVIROC IN TREATMENT-EXPERIENCED HIV PATIENTS IN BRAZIL

被引：0
|
作者：
Machado, M. [1 ]
Canella, M. [1 ]
Franco, E. [1 ]
Zajdenverg, R. [1 ]
机构：
[1] GlaxoSmithKline Brazil, Rio De Janeiro, Brazil
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.663
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A119 / A119
页数：1
相关论文
共 50 条
  • [1] Optimizing management of treatment-naive and treatment-experienced HIV+ patients: the role of maraviroc
    Poveda, Eva
    Soriano, Vincent
    [J]. HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2010, 2 : 51 - 58
  • [2] Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients
    Lorenzen, Thore
    [J]. HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2010, 2 : 151 - 156
  • [3] The MOTIVATE trials: maraviroc therapy in antiretroviral treatment-experienced HIV-1-infected patients
    van Lelyveld, Steven F. L.
    Wensing, Annemarie M. J.
    Hoepelman, Andy I. M.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (11) : 1241 - 1247
  • [4] Efficacy and safety of Maraviroc in treatment-experienced patients. Personal report
    Dell'Isola, C.
    Manzillo, E.
    Aprea, L.
    Franco, A.
    Pizzella, T.
    Simioli, F.
    Izzo, C. M.
    [J]. INFECTION, 2010, 38 : 60 - 60
  • [5] MARAVIROC IN TREATMENT-EXPERIENCED PATIENTS WITH HIV-1 INFECTION - EXPERIENCE FROM ROUTINE CLINICAL PRACTICE
    Reuter, S.
    Braken, P.
    Jensen, B.
    Sierra-Aragon, S.
    Oette, M.
    Balduin, M.
    Kaiser, R.
    Haeussinger, D.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (06) : 231 - 237
  • [6] Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice
    S Reuter
    P Braken
    B Jensen
    S Sierra-Aragon
    M Oette
    M Balduin
    R Kaiser
    D Häussinger
    [J]. European Journal of Medical Research, 15
  • [7] Five-Year Safety Evaluation of Maraviroc in HIV-1-Infected Treatment-Experienced Patients
    Gulick, Roy M.
    Fatkenheuer, Gerd
    Burnside, Robert
    Hardy, W. David
    Nelson, Mark R.
    Goodrich, James
    Mukwaya, Geoffrey
    Portsmouth, Simon
    Heera, Jayvant R.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (01) : 78 - 81
  • [8] THE ECONOMIC IMPACT OF MARAVIROC FOR ANTIRETROVIRAL TREATMENT-EXPERIENCED HIV-INFECTED INDIVIDUALS IN MEXICO
    Contreras-Hernandez, I
    Rely, K.
    Mould-Quevedo, J.
    Davila-Loaiza, G.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A116 - A116
  • [9] Cost-Effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-infected Individuals in Mexico
    Contreras-Hernandez, Iris
    Becker, Debbie
    Chancellor, Jeremy
    Kuehne, Felicitas
    Mould-Quevedo, Joaquin
    Vega, Gabriela
    Marfatia, Shalaka
    [J]. VALUE IN HEALTH, 2010, 13 (08) : 903 - 914
  • [10] A Microsimulation of the Cost-effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-Infected Individuals
    Kuehne, Felicitas C.
    Chancellor, Jeremy
    Mollon, Patrick
    Myers, Daniela E.
    Louie, Michael
    Powderly, William G.
    [J]. HIV CLINICAL TRIALS, 2010, 11 (02): : 80 - 99
12345